Annals of Hematology

, Volume 84, Issue 9, pp 578–583

Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease

  • Hongmei Ren
  • Iheanyi Okpala
  • Kebreab Ghebremeskel
  • Cynthia C. Ugochukwu
  • Obike Ibegbulam
  • Michael Crawford
Original Article


Leukocyte adhesion to vascular endothelium contributes to vaso-occlusion and widespread organ damage in sickle cell disease (SCD). Previously, we found high expression of the adhesion molecules αMβ2 integrin and L-selectin in HbSS individuals with severe disease. Since membrane n-6 and n-3 polyunsaturated fatty acids modulate cell adhesion, inflammation, aggregation and vascular tone, we investigated the fatty acid composition of mononuclear cells (MNC) and platelets of HbSS patients in steady state (n=28) and racially matched, healthy HbAA controls with similar age and sex distribution living in the same environment (n=13). MNC phospholipids of the patients had lower levels of docosahexaenoic acid (DHA, p<0.01) and increased arachidonic acid (AA, p<0.005) relative to HbAA controls. Similarly, platelets from HbSS patients had less eicosapentaenoic acid (EPA, p<0.05) and more AA (p<0.05) in choline phosphoglycerides (CPG), with reduced DHA (p<0.05) in ethanolamine phosphoglycerides. Platelet CPG had lower DHA levels in SCD patients with complications compared to those without (p<0.05). Reduced cell content of EPA and DHA relative to AA favours the production of aggregatory and proinflammatory eicosanoids that activate leukocytes and platelets. This facilitates inflammation, leukocyte adhesion, platelet aggregation and vaso-occlusion in SCD.


Sickle cell disease Mononuclear cells Platelets Lipids 


  1. 1.
    Anel A, Naval J, Gonzalez B, Uriel J, Pineiro A (1990) Fatty acid metabolism in human lymphocytes: II. Activation of fatty acid desaturase–elongase systems during blastic transformation. Biochim Biophys Acta 1044:332–339Google Scholar
  2. 2.
    Anyaegbu CC, Okpala IE, Aken’Ova AY, Salimonu LS (1998) Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA). Eur J Haematol 60:267–268Google Scholar
  3. 3.
    Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM (2000) Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96:2451–2459PubMedGoogle Scholar
  4. 4.
    Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM (1993) Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood 81:2137–2143Google Scholar
  5. 5.
    Calder PC (2003) N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38:343–352Google Scholar
  6. 6.
    Chiu D, Lubin B, Roelofsen B, Van Deenen LL (1981) Sickled erythrocytes accelerate clotting in vitro: an effect of abnormal lipid asymmetry. Blood 58:398–401Google Scholar
  7. 7.
    Folch J, Lees M, Slone-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497–509PubMedGoogle Scholar
  8. 8.
    Frenette PS (2002) Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 9:101–106CrossRefPubMedGoogle Scholar
  9. 9.
    Guyer DA, Moore KL, Lynam EB, Schammel CM, Rogelj S, McEver RP, Sklar LA (1996) P-selectin glycoprotein ligand (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 88:2415–2421Google Scholar
  10. 10.
    Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK (1996) Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 63:267–272Google Scholar
  11. 11.
    Kaul DK, Fabry ME, Nagel RL (1989) Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A 86:3356–3360Google Scholar
  12. 12.
    Kaul DK, Fabry ME, Nagel RL (1996) The pathophysiology of vascular obstruction in the sickle syndromes. Blood Rev 10:29–44Google Scholar
  13. 13.
    Khalfoun B, Thibault G, Bardos P, Lebranchu Y (1996) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte–endothelial cell adhesion. Transplantation 62:1649–1657Google Scholar
  14. 14.
    Kurantsin-Mills J, Ibe BO, Natta CL, Raj JU, Siegel RS, Lessin LS (1994) Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Br J Haematol 87:580–585Google Scholar
  15. 15.
    Laposata M, Reich EL, Majerus PW (1985) Arachidonoyl–CoA synthetase. Separation from nonspecific acyl–CoA synthetase and distribution in various cells and tissues. J Biol Chem 260:11016–11020Google Scholar
  16. 16.
    Mills DE, Galey WR, Dixon H (1993) Effects of dietary fatty-acid supplementation on fatty-acid composition and deformability of young and old erythrocytes. Biochim Biophys Acta 1149:313–318Google Scholar
  17. 17.
    Needleman SW, Spector AA, Hoak JC (1982) Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release. Prostaglandins 24:607–622Google Scholar
  18. 18.
    Nishiyama A, Cavaglieri CR, Curi R, Calder PC (2000) Arachidonic acid-containing phosphatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-gamma production from concanavalin A-stimulated rat lymphocytes. Biochim Biophys Acta 1487:50–60Google Scholar
  19. 19.
    Okpala IE, Daniel Y, Haynes R, Odoemene D, Goldman JM (2002) High expression of αMβ2 integrin and L-selectin by leukocytes of patients with severe manifestations of sickle cell disease. Blood 100 [Suppl]:11aGoogle Scholar
  20. 20.
    Okpala IE, Daniel Y, Haynes R, Odoemene D, Goldman JM (2002) Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 69:135–144Google Scholar
  21. 21.
    Okpala IE (2004) Epidemiology, genetics and pathophysiology of sickle cell disease. In: Okpala IE (ed) Practical management of haemoglobinopathies. Blackwell Publishing, Oxford, pp 20–25Google Scholar
  22. 22.
    Okpala IE (2004) The intriguing contribution of white blood cells to sickle cell disease—a red cell disorder. Blood Rev 18:65–73Google Scholar
  23. 23.
    Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644CrossRefPubMedGoogle Scholar
  24. 24.
    Powars DR (2000) Management of cerebral vasculopathy in children with sickle cell anaemia. Br J Haematol 108:666–678Google Scholar
  25. 25.
    Rodgers GP (1997) Overview of pathophysiology and rationale for treatment of sickle cell anemia. Semin Hematol 34:2–7Google Scholar
  26. 26.
    Schwartz RS, Tanaka Y, Fidler IJ, Chiu DT, Lubin B, Schroit AJ (1985) Increased adherence of sickled erythrocytes and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 75:1965–1972Google Scholar
  27. 27.
    Setty BN, Chen D, O’Neal P, Littrell JB, Grossman MH, Stuart MJ (1998) Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion. J Lab Clin Med 131:344–353Google Scholar
  28. 28.
    Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314CrossRefPubMedGoogle Scholar
  29. 29.
    Steinberg MH (1998) Pathophysiology of sickle cell disease. Baillieres Clin Haematol 11:163–184Google Scholar
  30. 30.
    Steinberg MH, Rodgers GP (2001) Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 38:299–306Google Scholar
  31. 31.
    Styles LA, Schalkwijk CG, Aarsman AJ, Vichinsky EP, Lubin BA, Kuypers FA (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell anaemia. Blood 87:2573–2578Google Scholar
  32. 32.
    Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK (1998) Interaction of sickle cell erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92:3924–3935PubMedGoogle Scholar
  33. 33.
    Tan P, Luscinskas FW, Homer-Vanniasinkams S (1999) Cellular and molecular mechanisms of inflammation and thrombosis. Eur J Vasc Endovasc Surg 17:373–389Google Scholar
  34. 34.
    Tomer A, Kasey S, Connor WE, Clark S, Harker LA, Eckman JR (2001) Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 85:966–974Google Scholar
  35. 35.
    Wun T, Cordoba M, Rangaswami A, Cheung AW, Paglieroni T (2002) Activated monocytes and platelet–monocyte aggregates in patients with sickle cell disease. Clin Lab Haematol 24:81–88Google Scholar
  36. 36.
    Yang J, Furie BC, Furie B (1999) The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte–endothelial and leukocyte–platelet interaction. Thromb Haemost 81:1–7Google Scholar
  37. 37.
    Yli-Jama P, Seljeflot I, Meyer HE, Hjerkinn EM, Arnesen H, Pedersen JI (2002) Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction. Atherosclerosis 164:275–281Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Hongmei Ren
    • 1
  • Iheanyi Okpala
    • 2
  • Kebreab Ghebremeskel
    • 1
  • Cynthia C. Ugochukwu
    • 2
  • Obike Ibegbulam
    • 3
  • Michael Crawford
    • 1
  1. 1.Institute of Brain Chemistry and Human NutritionLondon Metropolitan UniversityLondonUK
  2. 2.Department of Hematology, St. Thomas’ HospitalUniversity of LondonLondonUK
  3. 3.Department of HematologyUniversity of Nigeria Teaching HospitalEnuguNigeria

Personalised recommendations